Cognitive outcomes after multimodal treatment in adult glioma patients: A meta-analysis
Open Access
- 21 February 2023
- journal article
- review article
- Published by Oxford University Press (OUP) in Neuro-Oncology
- Vol. 25 (8) , 1395-1414
Abstract
Background: Cognitive functioning is increasingly assessed as a secondary outcome in neuro-oncological trials. However, which cognitive domains or tests to assess, remains debatable. In this meta-analysis, we aimed to elucidate the longer-term test-specific cognitive outcomes in adult glioma patients. Methods: A systematic search yielded 7098 articles for screening. To investigate cognitive changes in glioma patients and differences between patients and controls 1-year follow-up, random-effects meta-analyses were conducted per cognitive test, separately for studies with a longitudinal and cross-sectional design. A meta-regression analysis with a moderator for interval testing (additional cognitive testing between baseline and 1-year posttreatment) was performed to investigate the impact of practice in longitudinal designs. Results: Eighty-three studies were reviewed, of which 37 were analyzed in the meta-analysis, involving 4078 patients. In longitudinal designs, semantic fluency was the most sensitive test to detect cognitive decline over time. Cognitive performance on mini-mental state exam (MMSE), digit span forward, phonemic and semantic fluency declined over time in patients who had no interval testing. In cross-sectional studies, patients performed worse than controls on the MMSE, digit span backward, semantic fluency, Stroop speed interference task, trail-making test B, and finger tapping. Conclusions: Cognitive performance of glioma patients 1 year after treatment is significantly lower compared to the norm, with specific tests potentially being more sensitive. Cognitive decline over time occurs as well, but can easily be overlooked in longitudinal designs due to practice effects (as a result of interval testing). It is warranted to sufficiently correct for practice effects in future longitudinal trials.Keywords
Funding Information
- Flemish Foundation of Scientific Research (SB/1SE5722N, 12Y6122N)
This publication has 72 references indexed in Scilit:
- A meta-analysis of the effects of chemotherapy on cognition in patients with cancerCancer Treatment Reviews, 2013
- Evidence-Based Indicators of Neuropsychological Change in the Individual Patient: Relevant Concepts and MethodsArchives of Clinical Neuropsychology, 2012
- Awake surgery in low-grade gliomas harboring eloquent areas: 3-year mean follow-upNeurological Sciences, 2011
- Cognition and Quality of Life After Chemotherapy Plus Radiotherapy (RT) vs. RT for Pure and Mixed Anaplastic Oligodendrogliomas: Radiation Therapy Oncology Group Trial 9402International Journal of Radiation Oncology - Biology - Physics (IJROBP), 2010
- Health related quality of life and cognitive status in patients with glioblastoma multiforme receiving escalating doses of conformal three dimensional radiation on RTOG 98-03Journal of Neuro-Oncology, 2009
- Detrimental Effects of Tumor Progression on Cognitive Function of Patients With High-Grade GliomaJournal of Clinical Oncology, 2006
- Brain tumour surgery in the vicinity of short-term memory representation – results of neuronavigation using fMRI imagesActa Neurochirurgica, 2005
- Quantifying heterogeneity in a meta‐analysisStatistics in Medicine, 2002
- Cognitive functions and quality of life in patients with low‐grade gliomas: The impact of radiotherapyAnnals of Neurology, 1994
- Cognitive functioning in long-term survivors of high-grade gliomaJournal of Neurosurgery, 1994